These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1889377)

  • 21. Potentiation of carbon tetrachloride hepatotoxicity by piperine.
    Piyachaturawat P; Kingkaeohoi S; Toskulkao C
    Drug Chem Toxicol; 1995 Nov; 18(4):333-44. PubMed ID: 8586024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities.
    Koul S; Koul JL; Taneja SC; Dhar KL; Jamwal DS; Singh K; Reen RK; Singh J
    Bioorg Med Chem; 2000 Jan; 8(1):251-68. PubMed ID: 10968285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of hepatic cytochrome P-450 and drug metabolism by doxapram in the mouse.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Apr; 72(1):109-12. PubMed ID: 2052744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cholesterol and protein diet on liver cytochrome P-450-dependent monooxygenase system in rats.
    Plewka A; Kamiński M
    Exp Toxicol Pathol; 1996 Jun; 48(4):249-53. PubMed ID: 8811291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
    Farrell GC; Zaluzny L
    Gastroenterology; 1983 Aug; 85(2):275-82. PubMed ID: 6862153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of mixed-function oxidases and purified cytochrome P-450 of livers of house musk shrew, Suncus murinus.
    Mizokami K; Fukuhara M; Nohmi T; Sunouchi M; Fujimori K; Takanaka A; Omori Y
    Drug Metab Dispos; 1988; 16(1):151-5. PubMed ID: 2894946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of dietary monensin in quail.
    Sawant SG; Terse PS; Dalvi RR
    Avian Dis; 1990; 34(3):571-4. PubMed ID: 2241682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of piperonyl butoxide on hepatic delta-aminolevulinic acid synthetase activity in mice.
    Yoshida T; Suzuki Y; Uchiyama M
    Biochem Pharmacol; 1976 Nov; 25(21):2418-20. PubMed ID: 999733
    [No Abstract]   [Full Text] [Related]  

  • 30. The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB₁ receptor in vitro.
    Dhopeshwarkar AS; Jain S; Liao C; Ghose SK; Bisset KM; Nicholson RA
    Eur J Pharmacol; 2011 Mar; 654(1):26-32. PubMed ID: 21172340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic disposition of piperine in the rat.
    Bhat BG; Chandrasekhara N
    Toxicology; 1987 Apr; 44(1):99-106. PubMed ID: 3564049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of house fly microsomal mixed function oxidases: inhibition by juvenile hormone i and piperonyl butoxide.
    Fisher CW; Mayer RT
    Toxicology; 1982; 24(1):15-31. PubMed ID: 6814016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of drug-metabolizing enzymes in female sheep livers.
    Kaddouri M; Larrieu G; Eeckhoutte C; Galtier P
    J Vet Pharmacol Ther; 1990 Dec; 13(4):340-9. PubMed ID: 2287026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of repeated administration of monomethyl-aminoantipyrine on the activities of gamma-glutamyltranspeptidase and microsomal drug metabolizing enzymes in rat liver.
    Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):431-43. PubMed ID: 2862671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity.
    Baliga R; Zhang Z; Baliga M; Ueda N; Shah SV
    Kidney Int; 1998 Nov; 54(5):1562-9. PubMed ID: 9844132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cadmium administration and hepatic drug metabolizing enzyme system: effect of pretreatment with phenobarbital and 3-methyl cholanthrene.
    Mgbodile MU
    Biochem Int; 1983 Jan; 6(1):11-20. PubMed ID: 6679315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hydralazine on hepatic drug metabolizing enzymes in rats.
    Hara S; Satoh T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):260-72. PubMed ID: 7100630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature.
    Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W
    Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-related effects of imidacloprid modulated by piperonyl butoxide and menadione in rats. Part II: genotoxic and cytotoxic potential.
    Arslan M; Sevgiler Y; Buyukleyla M; Yardimci M; Yilmaz M; Rencuzogullari E
    Drug Chem Toxicol; 2016; 39(1):81-6. PubMed ID: 25826181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of endosulfan and dietary vitamin A on rat hepatic drug metabolising enzymes.
    Sriram K; Misra UK
    Acta Vitaminol Enzymol; 1983; 5(4):213-8. PubMed ID: 6424426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.